Chiome Bioscience Inc. (4583) — research page
JP · jp-cm-kg/TSE-GROWTH/4583 · as of 2026-11-06
Identity and listing
The issuer is Chiome Bioscience Inc., listed on the Growth Market under ticker 4583. The ISIN is not on the record and the LEI is not on the record. The security type is Corporate and the segment is not on the record. The sector is 3250 Pharmaceutical and the jurisdiction is Japan (EDINET domestic filer). The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Chiome Bioscience Inc. | source · 2026-11-06 |
| exchange | Growth Market | source · 2026-11-06 |
| ticker | 4583 | source · 2026-11-06 |
| ISIN | not on the record | |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | 3250 Pharmaceutical | source · 2026-11-06 |
| jurisdiction | Japan (EDINET domestic filer) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 8 filings in the twelve months to 2026-11-06, across 4 filing days. The median gap between filing days is 93 days. The latest filing is dated 2026-08-13 and is of type results, 85 days before the record date of 2026-11-06. The Growth Market median cadence gap is 42 days across 598 issuers, and the Growth Market median latency is 85.0 days. The 3250 Pharmaceutical sector median cadence gap is 49.5 days across 80 issuers, and the sector median latency is 85.0 days. The issuer's median filings count is 8 and the Growth Market and sector medians are both 8.0.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 8 | 93 | 85 |
| exchange median: Growth Market (598 issuers) | 8 | 42 | 85 |
| sector median: 3250 Pharmaceutical (80 issuers) | 8 | 49.5 | 85 |
| date | type | category | filing |
|---|---|---|---|
| 2026-08-13 | results | 半期報告書 (half-year report) | 半期報告書－第23期(2026/01/01－2026/12/31) |
| 2026-08-13 | regulatory_filing | 135 | 確認書 |
| 2026-03-27 | ad_hoc | 臨時報告書 (extraordinary report) | 臨時報告書 |
| 2026-03-27 | regulatory_filing | 235 | 内部統制報告書－第22期(2025/01/01－2025/12/31) |
| 2026-03-27 | regulatory_filing | 135 | 確認書 |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is 太 陽 有 限 責 任 監 査 法 人. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The issuer is listed and not halted.
Orderability
For the client category Qualified Institutional Investors, the outcome is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| Qualified Institutional Investors | not determinable: the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope |
rule acm-68000/jp/suitability-principle-fiea-article-40/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations page.
Open research
The record holds 4 openly published research notes. They are from Omega Investment dated 2023-12-12, Omega Investment dated 2023-06-01, Omega Investment dated 2021-08-23, and FISCO Ltd. dated 2014-10-27.
| date | publisher | note | kind |
|---|---|---|---|
| 2023-12-12 | Omega Investment | Chiome Bioscience | issuer-sponsored |
| 2023-06-01 | Omega Investment | Chiome Bioscience | issuer-sponsored |
| 2021-08-23 | Omega Investment | Chiome Bioscience | issuer-sponsored |
| 2014-10-27 | FISCO Ltd. | Company Research and Analysis Report: Chiome Bioscience Inc. | independent |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, and no earliest sealed date for the market is on the record. The live record began date is not on the record.
Sources
11 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
- 10.2
- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
- 10.3
- https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4583 (the disclosure lines)
- 10.4
- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
- 10.5
- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XUJT (the auditor)
- 10.6
- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://omega-inv.com/wp-content/uploads/2023/12/4583CBS2023Q3_EN1212.pdf (open research)
- 10.8
- https://omega-inv.com/wp-content/uploads/2023/05/4583CBS2023Q1_EN0601.pdf (open research)
- 10.9
- https://omega-inv.com/en/wp-content/uploads/sites/2/2021/08/4583CB2021Q2UD0827EN.pdf (open research)
- 10.10
- https://www.fisco.co.jp/wordpress/wp-content/uploads/chiom20141027_e.pdf (open research)
- 10.11
- https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4583 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"4583","exchange":"Growth Market"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:f625c819d8f51d93.